Scarica l'app Stockscreener
1.08
6.90%
-0.08
Dopo l'orario di chiusura:
1.07
-0.01
-0.93%
Precedente Chiudi:
$1.16
Aprire:
$1.18
Volume 24 ore:
1.19M
Relative Volume:
1.09
Capitalizzazione di mercato:
$108.39M
Reddito:
-
Utile/perdita netta:
$-20.31M
Rapporto P/E:
-4.0832
EPS:
-0.2645
Flusso di cassa netto:
$-21.07M
1 W Prestazione:
+0.93%
1M Prestazione:
+22.30%
6M Prestazione:
+66.15%
1 anno Prestazione:
+6.93%
Intervallo 1D:
$1.06
$1.19
Intervallo di 1 settimana:
$1.01
$1.245
Portata 52W:
$0.3258
$1.53
Oncolytics Biotech Inc Stock (ONCY) Company Profile
Nome
Oncolytics Biotech Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ONCY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ONCY
Oncolytics Biotech Inc
|
1.08 | 116.43M | 0 | -20.31M | -21.07M | -0.2645 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-13 | Iniziato | Lake Street | Buy |
| 2022-10-06 | Iniziato | Maxim Group | Buy |
| 2021-02-17 | Iniziato | H.C. Wainwright | Buy |
Oncolytics Biotech Inc Borsa (ONCY) Ultime notizie
Quantitative breakdown of Oncolytics Biotech Inc. recent moveWeekly Profit Report & Fast Gaining Stock Reports - Newser
Can momentum traders help lift Oncolytics Biotech Inc.July 2025 Outlook & Fast Entry High Yield Tips - Newser
Can Oncolytics Biotech Inc. stock outperform in a bear marketPortfolio Growth Summary & High Win Rate Trade Tips - khodrobank.com
Can Oncolytics Biotech Inc. reach all time highs this yearJuly 2025 Big Picture & Expert Approved Momentum Trade Ideas - khodrobank.com
How to use a screener to detect Oncolytics Biotech Inc. breakoutsMarket Growth Summary & Fast Gain Swing Trade Alerts - Newser
Cellectar Biosciences shares fall 1.24% premarket as Oncolytics Biotech Inc. gains FDA approval for breakthrough therapies. - AInvest
How hedge fund analytics apply to Oncolytics Biotech Inc. stock2025 Valuation Update & Advanced Technical Analysis Signals - Newser
What’s the recovery path for long term holders of Oncolytics Biotech Inc.Earnings Performance Report & Stepwise Entry and Exit Trade Signals - Newser
Multi asset correlation models including Oncolytics Biotech Inc.2025 Historical Comparison & Free Growth Oriented Trading Recommendations - Newser
Oncolytics Biotech shares rise 8.70% premarket after providing updated clinical safety data for pelareorep. - AInvest
What technical models suggest about Oncolytics Biotech Inc.’s comebackWeekly Stock Report & Safe Capital Growth Trade Ideas - Newser
What moving averages say about Oncolytics Biotech Inc.Inflation Watch & Target Return Focused Picks - Newser
Using data filters to optimize entry into Oncolytics Biotech Inc.July 2025 Short Interest & Verified High Yield Trade Plans - Newser
Tools to assess Oncolytics Biotech Inc.’s risk profileGap Down & Fast Entry and Exit Trade Plans - Newser
Does Oncolytics Biotech Inc. qualify in momentum factor screening2025 Market Sentiment & Safe Entry Trade Reports - Newser
Technical signs of recovery in Oncolytics Biotech Inc.Weekly Stock Summary & Expert Approved Momentum Trade Ideas - Newser
Leading vs lagging indicators on Oncolytics Biotech Inc. performanceQuarterly Profit Review & Target Return Focused Stock Picks - Newser
Using portfolio simulators with Oncolytics Biotech Inc. included2025 Top Decliners & Long-Term Safe Investment Plans - Newser
FDA Fast-Track Cancer Treatments Drive Market Surge as Innovations Accelerate - Baystreet.ca
Oncolytics Biotech Inc. recovery potential after sell off2025 Top Decliners & Fast Gain Swing Trade Alerts - Newser
Trend analysis for Oncolytics Biotech Inc. this weekJuly 2025 Institutional & Technical Buy Zone Confirmation - Newser
Cellectar Biosciences shares fall 1.45% after-hours as Oncolytics Biotech Inc. gains regulatory momentum. - AInvest
How to forecast Oncolytics Biotech Inc. trends using time seriesTrade Analysis Summary & Real-Time Market Sentiment Alerts - Newser
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands - The Ritz Herald
Oncolytics Biotech Updates Pelareorep Safety Data for Gastrointestinal Tumors - TipRanks
Oncolytics Biotech® Provides Updated Clinical Safety Data for Pelareorep, Including Across Multiple Gastrointestinal Tumors - Barchart.com
Published on: 2025-09-02 05:28:33 - Newser
Aug Setups: Will Oncolytics Biotech Inc. benefit from geopolitical trendsJuly 2025 Short Interest & Risk Managed Investment Signals - khodrobank.com
Pattern recognition hints at Oncolytics Biotech Inc. upsideMarket Volume Report & Expert Curated Trade Setups - Newser
Will Oncolytics Biotech Inc. stock recover after recent drop2025 Analyst Calls & Weekly High Return Forecasts - Newser
What is Oncolytics Biotech Inc.’s TAM (Total Addressable Market)Weekly Trend Recap & Entry Point Confirmation Signals - khodrobank.com
Is Oncolytics Biotech Inc. still worth holding after the dipQuarterly Risk Review & Long-Term Capital Growth Strategies - Newser
What’s the RSI of Oncolytics Biotech Inc. stockJuly 2025 Final Week & Daily Stock Trend Watchlist - khodrobank.com
Market reaction to Oncolytics Biotech Inc.’s recent newsJuly 2025 Momentum & Consistent Profit Alerts - Newser
What moving averages say about Oncolytics Biotech IncJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - Newser
Applying big data sentiment scoring on Oncolytics Biotech Inc.Bond Market & Safe Capital Investment Plans - Newser
Developing predictive dashboards with Oncolytics Biotech Inc. data2025 Big Picture & Long-Term Growth Stock Strategies - Newser
Oncolytics Biotech Inc Azioni (ONCY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):